Yandex NV (NASDAQ:YNDX) shares plunged today after Russia invaded Crimea, which is part of the Ukraine. Now Russia occupies a number of strategic locations in the area, and the U.S. and other nations in the West denounced the occupation, threatening sanctions if Russia doesn’t back off. Yandex is just one of several Russian companies with stocks that declined today in U.S. markets. Yandex NV (NASDAQ:YNDX) stock opened at $33.75 in last session, and closed at $32.23, while the day range of Yandex NV (NASDAQ:YNDX) stock is $31.55 – $34.47. The stock showed a positive weekly performance of -11.63%.
Shares of Capstone Turbine (NASDAQ:CPST) saw a large growth in short interest in the month of January. As of February 14th, there was short interest totalling 43,830,131 shares, a growth of 4.4% from the January 31st total of 41,965,722 shares, AnalystRatings.Net reports. Currently, 14.3% of the shares of the company are short sold. Capstone Turbine Corporation (NASDAQ:CPST) stock opened at $1.69 in last session, and closed at $1.62 by losing -9.50%. The 52 week range of $0.82 – $1.96. Company’s market capitalization is $499.62M.
Cell Therapeutics, Inc. (NASDAQ:CTIC) announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).Cell Therapeutics Inc. (NASDAQ:CTIC) stock decreased -5.71% and finished the last session at $3.63. The EPS of the stock remained -0.75. Company’s market capitalization is $402.92M.
The investigation concerns whether Akorn and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The Company announced in a regulatory filing that “The Company has not completed its testing and assessment of the effectiveness of its internal control over financial reporting due in part to identified control deficiencies related to completeness and accuracy of underlying data used in the determination of certain significant estimates and accounting transactions as well as the existence of inadequate segregation of duties. Akorn, Inc. (NASDAQ:AKRX) stock opened the session at $24.54, and closed the session at $24.10. The 52 week range of the Akorn, Inc. (NASDAQ:AKRX) stock remained $12.85 – $28.00 and the day range was $21.11 – $24.54.